medline.ch Respirationstrakt Neoplasie

	Immunotherapy after EGFRâ€‘TKI treatment in advanced nonâ€‘small cell lung cancer: Current status and future perspectives (Review) . Oncol Rep Ma H, Li L, Jiao C, Cheng Y, He J, Jiang C, Tong Q, Yi D, Zhang Y. PMID: 41543165 [PubMed - indexed for MEDLINE]
	Letter to the Editor: Association Between Immunotherapy and Overall Survival in Malnourished Patients with Advanced Non-Small Cell Lung Cancer: A Nationwide Retrospective Cohort Study in Japan. Nutr Cancer Li N, Chen H, Wang Y, Li X. PMID: 41542856 [PubMed - as supplied by publisher]
	Challenges and Limitations of Sequential MET-TKI Therapy in METex14- Positive NSCLC With a Focus on Non-ILD Toxicities: A Case Report. Cancer Rep (Hoboken) Nigi A, Kumasa T, Iwamoto K, Itani H, Kondou S, Uraki J. PMID: 41542718 [PubMed - indexed for MEDLINE]
	General practitioners' attitudes towards liquid biopsy as a diagnostic test for advanced lung cancer. J Liq Biopsy Lo D, Wong J, Keenan R, Fingleton J, Wong ANM. PMID: 41541744 [PubMed]
	Tumor suppressor genes and KRAS G12C inhibitor resistance in non-small cell lung cancer. iScience Zhu L, Jia X, Xu L, Chen L, Fu X, Yan H, Ai B, Peng S. PMID: 41541668 [PubMed]
	Burden of lung cancer and application of patient-reported outcomes in the Western Pacific Region: a systematic analysis. Front Med (Lausanne) Liu K, Gao Q, Wang X, Lan J, Tian T, Rong H. PMID: 41541505 [PubMed]
	Interventions targeted to improve lung cancer screening uptake among high-risk individuals: A systematic review and meta-analysis. Asia Pac J Oncol Nurs Yang Y, Zhao W, Chan DNS, Zhou S, Choi KC, So WKW. PMID: 41541011 [PubMed]
	Study of Imaging Analysis for Distinguishing Alveolar Collapse From Invasive Lesions in Early-Stage Lung Adenocarcinoma. Thorac Cancer Kaneda S, Ito A, Ito D, Kawaguchi T, Takao M, Kawaguchi K. PMID: 41540808 [PubMed - indexed for MEDLINE]
	Evolving Patterns of Care, Outcomes and Ongoing Challenges for Early-Stage Non-Small Cell Lung Cancer in the Immunotherapy Era: A Queensland Population-Based Study. Thorac Cancer Chan BA, Youlden DR, Pattison A, Guan T, Cossio D, Sanmugarajah J. PMID: 41540800 [PubMed - indexed for MEDLINE]
	A Cuproptosis-related lncRNA Signature for Prognostic Stratification and Immunotherapeutic Implications in Lung Adenocarcinoma. Curr Mol Med Jiang Y, Xing D, Luo K, Guo J, Zhai Y, Li C, He X, Wang J, Wu W, Zhao Z. PMID: 41540526 [PubMed - as supplied by publisher]
	Textbook outcome and long-term survival after pulmonary resection for non-small cell lung cancer: a retrospective cohort study. World J Surg Oncol Raykateeraroj N, Chu F, Suh JM, Petterlin L, Francis E, Zhao J, Ratnayakemudiyanselage P, Navaz FAP, Ker CJ, Roshanaei S, Botta H, Elias J, Ling E, Ma R, Barnett SA, Knight S, Lee DK, Weinberg L. PMID: 41540440 [PubMed - as supplied by publisher]
	High endothelial venules abundance in tertiary lymphoid structures: a prognostic biomarker in non-small cell lung cancer with neoadjuvant immunochemotherapy. BMC Cancer Zhang Y, Xie M, Gao J, Ma X, Yao J, Lin X, Bao X, Zhang X, Li K, Du A, Wei B, Zang X, Xue X. PMID: 41540369 [PubMed - as supplied by publisher]
	Single and multi-site CT-based radiogenomics analysis of metastatic lung adenocarcinoma and correlations with outcome. Eur Radiol Crombé A, Sitruk LA, Masson-Grehaigne C, Lafon M, Palussiere J, Bonhomme B, Cousin S, Lassau N, Italiano A. PMID: 41540209 [PubMed - as supplied by publisher]
	Segmented jaw-locking in IMRT for upper thoracic esophageal cancer: A plan complexity-driven approach to lung dose reduction. J Appl Clin Med Phys Cao S, Sun GZ, Gao JY, Dai X, Wang H, Chen CM, Xu WS, Fang YH. PMID: 41539939 [PubMed - indexed for MEDLINE]
	Aumolertinib as adjuvant therapy in resected EGFR-mutated non-small-cell lung cancer (ARTS): a double-blind, multicentre, randomised, controlled, phase 3 trial. Lancet Oncol Zhang L, Zhang X, Wu L, Xing W, Liu C, Zhang P, Chen K, Shi J, Xu S, Zhang X, Dong X, Fang H, Yu X, Gao Y, Li G, Chen Z, Fan S, Zhang X, Cheng Y. PMID: 41539318 [PubMed - as supplied by publisher]
	Preclinical characterization and first-in-human, phase I trial of the novel ALK inhibitor dirozalkib in advanced non-small cell lung cancer. Eur J Cancer Ai X, Guo R, Zhang L, Fang J, Zhang Y, Chen J, Zhao J, Ye F, Wang S, Shi M, Zhang X, Zhang F, Li J, Wang L, Guo X, Xu L, Duan X, Hu Y, Lu S. PMID: 41539180 [PubMed - as supplied by publisher]
	Targeting driver mutations in lung cancer with interstitial pneumonia: A nationwide study in Japan. Eur J Cancer Ikeda S, Ogura T, Misumi T, Nishioka Y, Hashimoto S, Ichikado K, Fukuizumi A, Takata S, Itoh T, Sato Y, Okishio K, Yatera K, Sakamoto N, Kato M, Kikuchi R, Honda T, Hashimoto N, Murakami K, Isshiki T, Yamane M, Karayama M, Miyamoto A, Ishida Y, Inomata M, Nishikiori H, Yamaguchi K, Amimoto H, Tamura K, Yanagihara T, Tanino Y, Koyama J, Tsurumaki N, Waseda Y, Kishaba T, Ozasa H, Matsumoto M, Kinoshita Y, Nakamura Y, Yamauchi H, Kishi K. PMID: 41539179 [PubMed - as supplied by publisher]
	Incidence of Pneumonitis in Asian Patients With Lung Cancer: A Systematic Literature Review and Meta-analysis. Clin Lung Cancer Kuang Y, Zu K, Xing D, Liu A, Uyei J, Nevo A, Chang HC, Pierce CM. PMID: 41539026 [PubMed - as supplied by publisher]
	Minimal Residual Disease Enhances Prognostic Stratification Beyond Pathological Response in Resectable Non-Small Cell Lung Cancer. Clin Cancer Res Provencio M, Serna-Blasco R, Nadal E, González Larriba JL, Martinez-Marti A, Bernabé Caro R, Bosch-Barrera J, Calvo V, Insa Molla A, Reguart N, de Castro Carpeño J, Aguado de la Rosa C, Palmero Sanchez R, Hernando Trancho F, Martín-López J, Rodríguez-Festa A, Mediavilla-Medel P, Lázaro M, Hayes J, Cruz-Bermúdez A, Massutí B, Romero A. PMID: 41537692 [PubMed - as supplied by publisher]
	Mesothelioma Contrast Pharmacokinetics: A Feasibility Trial of the Use of Pharmacokinetic Analysis in Small-Volume Pleural Malignancy. Radiol Cardiothorac Imaging Cowell GW, Tsim S, Stobo DB, Noble C, Humphreys CA, Woodward R, Foster JE, Dick C, Blyth KG. PMID: 41537688 [PubMed - indexed for MEDLINE]

Artikel 1 - 20 / 156512

Seite 1 von 7826



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung